Chart of the Day - Alexion Pharmaceuticals (ALXN)

The "Chart of the Day" is Alexion Pharmaceuticals (ALXN), which showed up on Monday's Barchart "All Time High" list. Alexion on Monday posted a new all-time high of $88.50 and closed up +3.71%. TrendSpotter has been Long since Dec 20 at $68.99. In recent news on the stock, Goldman Sachs on March 2 reiterated Alexion as a Conviction Buy based on the company's high growth potential, attractive drug portfolio, and status as a potential M&A buyout candidate. UBS on Feb 23 upgraded Alexion to a Buy from Neutral and raised the target to $99 from $73. Alexion Pharmaceuticals, with a market cap of $14 billion, develops pharmaceutical products for the treatment of heart disease, and inflammation, diseases of the immune system and cancer in humans.